Health and Fitness Health and Fitness
Wed, February 6, 2013
Tue, February 5, 2013
Mon, February 4, 2013
Sun, February 3, 2013
Sat, February 2, 2013
Fri, February 1, 2013
Thu, January 31, 2013
Wed, January 30, 2013
Tue, January 29, 2013
[ Tue, Jan 29th 2013 ] - Market Wire
AtheroNova Launches New Website
Mon, January 28, 2013
Sun, January 27, 2013
Sat, January 26, 2013
Fri, January 25, 2013
Thu, January 24, 2013
Wed, January 23, 2013
Tue, January 22, 2013
Mon, January 21, 2013
Fri, January 18, 2013
Thu, January 17, 2013
Wed, January 16, 2013
Tue, January 15, 2013
Mon, January 14, 2013
Fri, January 11, 2013
Thu, January 10, 2013

Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.


//health-fitness.news-articles.net/content/2013/ .. es-investigation-of-map-pharmaceuticals-inc.html
Published in Health and Fitness on Saturday, January 26th 2013 at 9:30 GMT by Market Wire   Print publication without navigation


BALA CYNWYD, Pa.--([ ])--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of MAP Pharmaceuticals, Inc. (aMAPa or the aCompanya) (Nasdaq: MAPP) relating to the proposed acquisition by Allergan, Inc. (aAllergana).

Under the terms of the transaction, MAP shareholders will receive only $25.00 in cash for each share of MAP stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of MAP for not acting in the Companyas shareholders' best interests in connection with the sale process to Allergan. MAP is expected to receive a decision on its inhalable migraine treatment Levadex by the Food and Drug Administration before mid-April. It has been reported that the global migraine drug market will reach $5.8 billion by 2021.

If you own shares of MAP stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ] visiting [ http://brodsky-smith.com/530-mapp-map-pharmaceuticals-inc.html ], by calling toll free 877-LEGAL-90.


Publication Contributing Sources